Breast Cancer Foundation NZ
PREDICT 5-FU
Recruiting
Updated: February 18, 2021
The purpose of this study is to investigate whether it is possible for blood samples to be used to monitor whether the correct dose of cancer medicines are being provided to patients.
Who is it for?
You may be eligible for this study if you are an adult who is receiving fluorouracil (5-FU) or capecitabine for the treatment of cancer.
Study details
All participants in this study will need to provide two blood samples and one dried blood spot sample at two visits with a pathologist. Any results from these samples will then be provided to your oncologist.
It is hoped that this research will help determine if it is possible to monitor the dose of medication needed per individual using blood samples.
Australia
Gosford Hospital, Central Coast
Wyong Public Hospital, Central Coast
Dubbo Base Hospital, Dubbo
Lake Macquarie Private Hospital, Lake Macquarie
Peter MacCallum Cancer Centre, Melbourne
Bankstown-Lidcombe Hospital, Sydney
Liverpool Hospital, Sydney
Wollongong Hospital, Wollongong
Wyong Public Hospital, Central Coast
Dubbo Base Hospital, Dubbo
Lake Macquarie Private Hospital, Lake Macquarie
Peter MacCallum Cancer Centre, Melbourne
Bankstown-Lidcombe Hospital, Sydney
Liverpool Hospital, Sydney
Wollongong Hospital, Wollongong
Contact:
Jennifer MartinIf you think you might be a candidate for this trial, use the contact details supplied, or talk to your doctor.
Want to access a trial that's not in your area? It's not always possible, but if you're interested, email us at intouch@bcf.org.nz
Interested in a clinical trial?
Subscribe for updates & stay in the loop with new studies.